KING DRUG COMPANY OF FLORENCE, INC vs. CEPHALON, INC., ET AL

Filing 1073

MEMORANDUM AND ORDER THAT STATUS CONFERENCE SET FOR 9/18/2017 04:00 PM. SIGNED BY HONORABLE MITCHELL S. GOLDBERG ON 8/28/17. 8/28/17 ENTERED AND COPIES MAILED, EMAILED.(rf, ) Modified on 8/28/2017 (rf, ).

IN THE UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF PENNSYLVANIA

______________________________________________________________________________
:
KING DRUG COMPANY OF FLORENCE, INC., :
CIVIL ACTION
et al.,
:
Plaintiffs,
:
:
v.
:
No. 2:06-cv-1797
:
CEPHALON, INC., et al.,
:
Defendants.
:
_________________________________________ :__________________________________
ORDER
AND NOW, this 28th day of August, 2017, upon consideration of “King Drug Direct
Purchaser Class Plaintiffs’ Supplemental Motion for Certification of the Direct Purchaser Class”
(doc. nos. 1034 and 1036), “Ranbaxy’s Opposition to Direct Purchaser Class Plaintiffs’
Supplemental Motion for Certification of the Direct Purchaser Class” (doc. no. 1050),
“Ranbaxy’s Supplemental Opposition to Direct Purchaser Class Plaintiffs’ Supplemental Motion
for Certification of the Direct Purchaser Class” (doc. no. 1053), “King Drug Direct Purchaser
Class Plaintiffs’ Reply Memorandum of Law in Support Suppert of their Supplemental Motion
for Certification of the Direct Purchaser Class” (doc. no. 1062), “Direct Purchaser Class
Plaintiffs’ Notice of Supplemental Authority Concerning American Sales Company, LLC v.
Pfizer, Inc.” (doc. no. 1069), following a hearing and in accordance with the accompanying
Memorandum Opinion, it is hereby ORDERED that the motion is DENIED.
It is further ORDERED that a telephone status conference is SCHEDULED for Monday
September 18, 2017 at 4:00 p.m. to discuss moving this case forward. Counsel for Plaintiffs

1

shall intitiate the telephone conference with counsel for Defendants prior to contacting
Chambers.
BY THE COURT:
/s/ Mitchell S. Goldberg
______________________________
Mitchell S. Goldberg, J.

2